Last reviewed · How we verify
Nausea and vomiting
Approved treatments
- Thorazine · Generic (originally Rhône-Poulenc/Sanofi)
- ALIZAPRIDE
- Motilium · Rabin Medical Center
- Dimenhydrinate · Alra
- Ethylthioperazine · Novartis
- Psyquil
- Phenergan · Generic (originally Wyeth/Pfizer)
- Trilafon
- Compazine · GSK
- Motilium · Johnson & Johnson (Janssen)
- Domperidon · Gadjah Mada University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nausea and vomiting patent landscape — cliff calendar, originator estates, attackable patents
- Nausea and vomiting treatment landscape brief
- Nausea and vomiting treatment updates RSS
Frequently asked questions about Nausea and vomiting
What drugs treat Nausea and vomiting?
Tracked treatments include Thorazine, ALIZAPRIDE, Motilium, Dimenhydrinate, Ethylthioperazine, Psyquil, Phenergan, Trilafon.
What is the treatment for Nausea and vomiting?
Standard treatment for Nausea and vomiting includes Thorazine, ALIZAPRIDE, Motilium, Dimenhydrinate, Ethylthioperazine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nausea and vomiting patent cliff · Nausea and vomiting CI report
- Treatment: Thorazine · Generic (originally Rhône-Poulenc/Sanofi)
- Treatment: ALIZAPRIDE
- Treatment: Motilium · Rabin Medical Center
- Treatment: Dimenhydrinate · Alra
- Treatment: Ethylthioperazine · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing